Stories
Marico Boosts Stake in Plix Owner Satiya Nutraceuticals to 84% with Rs 1,012 Crore Deal
- •Marico acquired an additional 24.09% stake in Satiya Nutraceuticals, the parent company of Plix, for Rs 1,012.03 crore.
- •The transaction increases Marico's total holding in the plant-based nutrition and wellness brand to 84.09% on a fully diluted basis.
- •The final tranche to acquire the remaining 14.09% stake is scheduled for completion in July 2027.
- •Satiya Nutraceuticals reported a consolidated turnover of Rs 864.31 crore for FY2025-26, showing rapid revenue growth.
- •The acquisition aligns with Marico's ongoing diversification strategy into health, wellness, and digital-first brands.
Key Questions Answered
Marico has acquired an additional 24.09% stake in Satiya Nutraceuticals, the owner of Plix, for ₹1,012.03 crore, bringing its aggregate holding to 84.09% on a fully diluted basis. With this transaction, Marico's cumulative investment in the business has reached ₹1,392.07 crore.
Marico expects to acquire the final 14.09% remaining stake in Satiya Nutraceuticals in July 2027, subject to the terms of the definitive agreements. The consideration for this final tranche will include a base amount of up to ₹592 crore alongside milestone-linked additions.
Satiya Nutraceuticals reported a consolidated turnover of ₹864.31 crore for the financial year 2025-26, marking substantial growth from ₹432.84 crore in FY2024-25 and ₹155.32 crore in FY2023-24. This represents more than a fivefold increase in turnover over a two-year period.
